ActionIQ has pushed its series C round to $100m following an extension from existing shareholders.

Lundbeckfonden Ventures and Chiesi Ventures have once again invested in the ocular oncology therapy developer, which has now raised $191m in total.

The firm specialises in setting up spinouts out of universities and corporations, and now has more than $1.6bn in assets under management.

Rapid7 took part in the industrial cybersecurity platform developer's latest round, following $10m from investors including Mitsui Fudosan in 2017.

Providence's health capacity management system has been spun off with $20m from investors including Providence Ventures and Kaiser Permanente Ventures

The Access Industries-backed content engagement software producer will be valued above $11bn once the reverse merger closes.

The on-demand consumer delivery service more than doubled its valuation to $8.9bn in under six months, in a round backed by SoftBank Vision Fund 1.

The McKesson-backed healthcare analytics software provider boosted its valuation to $3.3bn in a series E round that came just two months after its series D.

Novo and Lundbeck are in line for exits from the mitochondrial disease therapy developer, which has raised $145m across two funding rounds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.